Showing results (1981-1990 of 2,088) with videos related to
Sort By:
Pageof 209
Blood Advances|August 21, 2023
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphomaRaphael E Steiner, Steven R Hwang, Arushi Khurana, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyHervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.British Journal of Haematology|December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphomaBrian T Hill, Loretta Nastoupil, Allison M Winter, et al.Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCLKerstin Wenzl, Matt Stokes, Joseph P Novak, et al.Blood Cancer Journal|August 8, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohortsPatrizia Mondello, Brianna Negaard, Andrew L Feldman, et al.Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.European Journal of Personality|April 2, 2026
Value incoherence precedes value change: Evidence from value development in childhood and adolescence across culturesElla Daniel, Anat Bardi, Julie A Lee, et al.International Journal of Cancer|January 22, 2019
Plasma metabolites associated with colorectal cancer: A discovery-replication strategyAnne J M R Geijsen, Stefanie Brezina, Pekka Keski-Rahkonen, et al.Nature Medicine|April 3, 2019
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancerJakob Wirbel, Paul Theodor Pyl, Ece Kartal, et al.Nature Medicine|July 21, 2015
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H Wilson, Ryan M Young, Roland Schmitz, et al.Pageof 209